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Summary
Objective: Detection of focal cortical dysplasia (FCD) is of paramount impor-
tance in epilepsy presurgical evaluation. Our study aims at utilizing quantitative
positron emission tomography (QPET) analysis to complement magnetic reso-
nance imaging (MRI) postprocessing by a morphometric analysis program (MAP)
to facilitate automated identification of subtle FCD.
Methods: We retrospectively included a consecutive cohort of surgical patients
who had a negative preoperative MRI by radiology report. MAP was performed
on T1‐weighted volumetric sequence and QPET was performed on PET/computed
tomographic data, both with comparison to scanner‐specific normal databases.
Concordance between MAP and QPET was assessed at a lobar level, and the sig-
nificance of concordant QPET‐MAP+ abnormalities was confirmed by postresec-
tive seizure outcome and histopathology. QPET thresholds of standard deviations
(SDs) of −1, −2, −3, and −4 were evaluated to identify the optimal threshold for
QPET‐MAP analysis.
Results: A total of 104 patients were included. When QPET thresholds of SD =
−1, −2, and −3 were used, complete resection of the QPET‐MAP+ region was
significantly associated with seizure‐free outcome when compared with the partial
resection group (P = 0.023, P < 0.001, P = 0.006) or the no resection group
(P = 0.002, P < 0.001, P = 0.001). The SD threshold of −2 showed the best
combination of positive rate (55%), sensitivity (0.68), specificity (0.88), positive
predictive value (0.88), and negative predictive value (0.69). Surgical pathology
of the resected QPET‐MAP+ areas revealed mainly FCD type I. Multiple QPET‐
MAP+ regions were present in 12% of the patients at SD = −2.
Significance: Our study demonstrates a practical and effective approach to com-
bine quantitative analyses of functional (QPET) and structural (MAP) imaging
data to improve identification of subtle epileptic abnormalities. This approach can
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be readily adopted by epilepsy centers to improve postresective seizure outcomes
for patients without apparent lesions on MRI.
KEYWORD S
focal cortical dysplasia, MRI postprocessing, MRI-negative epilepsy, presurgical evaluation,
quantitative positron emission tomography
1 | INTRODUCTION
In the presurgical evaluation of magnetic resonance imag-
ing (MRI)‐negative (“nonlesional”) pharmacoresistant focal
epilepsy patients, identifying a previously undetected subtle
abnormality often helps refocus the surgical hypothesis.
Intracranial recordings can sometimes be omitted when the
location of the subtle abnormality has good congruence
with other noninvasive data. It was shown that many of
these previously undetected subtle abnormalities are focal
cortical dysplasia (FCD)1 and can easily be missed during
routine visual assessment of MRI because of their small
size and subtle morphological characteristics.2 As such,
many MRI postprocessing techniques have been investi-
gated to improve FCD detection.3-8 A number of studies
including our own have shown the usefulness of a morpho-
metric analysis program (MAP), implemented based on
algorithms of statistical parametric mapping (SPM) soft-
ware,6 to help detect subtle abnormalities in MRI‐negative
surgical candidates.6,9–16 One of the shortcomings of the
current MAP methodology is that imaging artifacts, regis-
tration errors, and normal variants may lead to multiple
regions on the output maps with high z scores; some may
resemble epileptogenic lesions. To reduce potential
false‐positive errors, a MAP‐guided visual analysis by a
dedicated neuroradiologist is needed to decide on the
significance of the findings. In this study, we aimed to
incorporate information from another noninvasive modality,
interictal 18F fluorodeoxyglucose positron emission tomog-
raphy (PET), to automate the identification of those MAP
findings relevant to epilepsy.
As a noninvasive whole‐brain imaging modality, PET
helps identify and map the metabolic change associated
with epilepsy, and therefore should provide complementary
functional information to structural MRI postprocessing
techniques. The identification of focal PET abnormalities
has been shown to help formulate preoperative clinical
hypotheses, positively impact intracranial electrode implan-
tation plans, and increase the likelihood of successful surgi-
cal intervention.17-19 Computational tools can help provide
objective data and may increase the diagnostic yield of
PET, especially in visually “normal” PET scans.20-24
In this study, we utilized quantitative processing of PET
(QPET) in combination with MAP to automatically and
objectively identify epileptogenic abnormalities in a cohort
of MRI‐negative epilepsy patients. We hypothesized that
concordant regions coidentified by MAP and QPET would
be epileptogenic, and the resection of these regions would
positively associate with more favorable postresective sei-
zure outcomes.
2 | MATERIALS AND METHODS
2.1 | Design and rationale
This retrospective study was approved by the Cleveland
Clinic Institutional Review Board. In all patients, the
strategies for intracranial electroencephalographic (EEG)
implantation and surgical resection were discussed at a
patient management conference. Recommendations were
made based on available multimodality data that included
MRI, seizure semiology, video‐electroencephalography,
PET, subtraction ictal single photon emission computed
tomography (CT) coregistered to MRI, and magnetoen-
cephalography (MEG). The results of QPET‐MAP analy-
ses were not used to inform diagnostic and treatment
recommendations.
Key Points
• We propose a multimodal approach to combine
quantitative analyses of PET and MRI data to
improve identification of subtle epileptic abnor-
malities
• We tested the efficacy of this approach in 104
consecutive patients with a negative preoperative
MRI by official radiology report
• Complete resection of the QPET-MAP+ region
was significantly associated with seizure-free out-
come at QPET SD thresholds of −1, −2, and −3
• The QPET SD threshold of −2 showed the best
combination of positive rate, sensitivity, speci-
ficity, positive predictive value, and negative pre-
dictive value
• Surgical pathology of the resected QPET-MAP+
areas revealed mainly FCD type I
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2.2 | Patient selection
We identified patients by reviewing the epilepsy surgical
database over a 6‐year period (2009‐2015). Patients were
included if they had (1) a preoperative 1.5‐T or 3‐T MRI
with T1‐weighted volumetric sequence, (2) MRI initially
read as negative on an official neuroradiology report, (3) a
preoperative PET scan on Siemens Biograph PET/CT scan-
ner (Siemens Medical Systems, Erlangen, Germany), (4)
>12 months of postsurgical follow‐up, and (5) a postopera-
tive MRI. Patients were excluded if they had (1) poor MRI
or PET quality hindering clinical read (as stated in the clin-
ical report) or (2) poor MRI or PET quality causing signifi-
cant registration errors in postprocessing procedures.
2.3 | MRI acquisition and postprocessing
Twenty‐five patients had 1.5‐T MRI, and 79 patients had 3‐T
MRI. Detailed MRI parameters and normal database informa-
tion can be found elsewhere.12 MAP was processed using
SPM12 toolbox (Wellcome Department of Cognitive Neurol-
ogy, London, UK) in MATLAB 2015a (MathWorks, Natick,
MA, USA) following previously established methods.6,10
MAP was performed on T1‐weighted volumetric sequences.
For each patient in this study, the main computed output was
a junction map, which highlighted brain structures deviating
from the average normal database; this difference was mea-
sured statistically using a z score, which may indicate the pres-
ence of subtle gray‐white blurring on the MRI.
2.4 | PET acquisition and QPET
The interictal 18F fluorodeoxyglucose PET/CT was
acquired on a Siemens Biograph mCT scanner. Acquisition
parameters can be found elsewhere.25 Simultaneous elec-
troencephalography was acquired during the PET study so
that ictal events could be monitored. All patients included
in this study had interictal PET. Visual PET analysis results
were obtained from the original official PET reports used
to guide clinical decisions; the reports were issued by a
dedicated nuclear medicine physician (G.W.).
QPET analysis was performed using the Syngo.via software
(VB10B; Siemens).26-28 The attenuation‐corrected PET images
were first fused with CT via rigid registration and then aligned
to a scanner‐specific normal database using deformable regis-
tration. The PET images were subsequently smoothed using a
12‐mm full‐width half‐maximum isotropic Gaussian kernel to
reduce the effect of image noise and nonphysiological intensity
variance due to reconstruction. Whole‐brain intensity was nor-
malized to eliminate global uptake differences between the
patient's PET image and the normal database. Separate normal
databases were used depending on patient age: a younger nor-
mal database with age range 19‐44 years (10 females, 28
males) and an older normal database with age range 46‐
79 years (22 females, 11 males). Statistical analyses were per-
formed on a voxel basis, and the difference in standard devia-
tions (SDs) compared to the normal database was recorded.
This was an automated quantification method, and the results
did not depend on the user. The final image output included the
original PET images, the QPET images (ie, the statistical
maps), and the coregistered MRI images on coronal, axial, and
sagittal views; all output images were segmented into prede-
fined sublobar regions. The process also generated a detailed
list of standardized uptake values and SDs in comparison with
the normal database in all the sublobar regions.
2.5 | QPET‐MAP review
Analyses and review of MAP and QPET were performed
blinded to patients’ clinical information. The candidate
MAP+ regions were defined using a z score threshold of 4
on the junction images, consistent with the literature.12,14,16
The candidate MAP+ regions in the entire brain were exam-
ined. High z score areas caused by signal inhomogeneity due
to technical reasons, nonspecific white matter lesions, and
motion or pulsation artifacts were not included. The QPET+
regions were generated using four different thresholds (SD =
−1, −2, −3, −4) to evaluate the significance of the QPET‐
MAP findings at each threshold. For each candidate MAP+
region, if there was sublobar concordance with a
suprathreshold QPET+ region, or if there was a suprathresh-
old QPET+ sublobar region within the same lobe (the whole
brain was divided into 12 regions: left and right frontal, pari-
etal, temporal, and occipital lobes, as well as cingulum and
insula), then the QPET‐MAP+ analysis was considered posi-
tive; otherwise, the QPET‐MAP+ analysis was considered
negative. All QPET findings were independently confirmed
by a dedicated nuclear medicine physician (G.W.) who was
blinded to the clinical data and MAP findings. The final
QPET‐MAP+ regions were further re‐reviewed by a dedi-
cated neuroradiologist (S.E.J.), who made a judgment as to
whether the original MRI showed subtle abnormalities in the
QPET‐MAP+ regions. Note that the QPET‐MAP+ regions
are the MAP+ regions with QPET concordance (not the
QPET+ regions with MAP concordance).
2.6 | Asymmetry index
For patients with temporal lobe epilepsy with bilateral tem-
poral hypometabolism shown on QPET, we additionally
calculated the asymmetry index based on standardized
uptake values of the temporal sublobar regions generated by
Syngo.via. Asymmetry ratio was defined by (left − right) /
[(left + right) / 2] × 100%.29 An asymmetry ratio ≤−10%
in any temporal sublobar region was used to indicate left‐
sided temporal hypometabolism, and an asymmetry ratio
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≥10% was used to indicate right‐sided temporal hypometa-
bolism.
2.7 | Surgical pathology
Available microscopic slides from surgical resections were
re‐reviewed in all cases by a dedicated neuropathologist
(R.A.P.). FCD was classified according to the International
League Against Epilepsy classification.30 Positive pathol-
ogy was defined as FCD, hippocampal sclerosis (HS), or
other (detailed in Results). Negative pathology was defined
by gliosis, hamartia, or the absence of any identifiable
microscopic/histological abnormalities.
2.8 | Statistical analyses
The postoperative MRI of each patient was coregistered with
the preoperative MRI using SPM12, so that complete or
incomplete resections of the QPET‐MAP+ regions can be
determined. The completeness of resection of the QPET‐
MAP+ regions was determined by whether the finding was
included in the resection cavity on the postoperative MRI. If
QPET‐MAP+ had multiple findings, all the findings would
need to be resected for the case to considered to be com-
pletely resected. Surgical outcome at 12 months was classi-
fied into two groups: completely seizure‐free (Engel class Ia)
and not seizure‐free (Engel class Ib‐IV).31 We used Pearson
chi‐square test to assess the relationship of parameters and
seizure outcomes; Fisher’s exact test was used when the cell
size was less than five; t tests and Wilcoxon rank‐sum tests
were used to compare the association of age and epilepsy
duration with outcomes. Positive rates of QPET‐MAP were
calculated at four QPET SD thresholds: −1, −2, −3, and −4.
Sensitivity, specificity, positive predictive value, and nega-
tive predictive value were also calculated at these four
thresholds. Positive rate is defined as the number of QPET‐
MAP+ cases/number of the entire cohort. True positive is
defined as QPET‐MAP+ region fully resected and patient
became seizure‐free, false positive as QPET‐MAP+ region
fully resected and patient did not become seizure‐free, true
negative as QPET‐MAP+ region not/partially resected and
patient did not become seizure‐free, and false nega-
tive as QPET‐MAP+ region not/partially resected and
patient became seizure‐free. SAS 9.3 software (SAS Insti-
tute, Cary, NC, USA) was used for all analyses. Our study
work flow is detailed in Figure 1.
3 | RESULTS
3.1 | Patient demographics
A total of 104 patients fulfilled the study selection criteria.
Detailed patient demographics and clinical data are given
in Table 1. Sixty‐two of the 104 patients (60%) were sei-
zure‐free at 12‐month follow‐up. Gender, handedness, age,
age group (adult or pediatric), epilepsy duration, type of
resection (temporal or extratemporal), and type of invasive
evaluation were not significantly associated with seizure‐
free outcome. There was no significant difference in sei-
zure‐free outcome between patients who were studied with
invasive evaluation and those who were not (P = 0.39).
Positive surgical pathology included FCD in 71 (68%),
HS in five (5%), FCD associated with HS in two (2%), and
other pathology in four (4%, microglial cell proliferation in
one and remote infarct in three). In the 71 patients with
FCD, FCD IIb was found in six, IIa in six, Ib in 34, and Ic
in 25. Seventeen patients (16%) had negative surgical
pathology. Five patients (5%) did not have adequate tissue
samples for pathological examination. The existence of
positive surgical pathology was not associated with seizure‐
free outcome (P = 0.86).
Visual PET analysis on 104 patients revealed 27 lobar
localizations, 22 unilateral multilobar findings, 11 bitempo-
ral findings with clear asymmetry, six bitemporal findings
without clear asymmetry, 52 bilateral findings (more exten-
sive than bitemporal), and three negative findings. The
FIGURE 1 Work flow of data collection and analysis. Patients
were retrospectively screened according to the inclusion and
exclusion criteria. Patients included in the study first underwent
morphometric analysis program (MAP) processing. Then, the patients
with candidate MAP+ regions underwent quantitative positron
emission tomography (QPET) analysis (patients with a MAP‐negative
finding did not undergo further analysis with QPET). Finally, the
QPET‐MAP+ regions were compared with the location of surgical
resection, and association with seizure outcomes was calculated. MRI,
magnetic resonance imaging
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existence of lobar localization by visual PET analysis did
not associate with seizure‐free outcome (P = 0.39).
3.2 | Candidate MAP+ regions
Candidate MAP+ regions were found in 82 of the 104
patients (79%), including 34 patients with single candidate
MAP+ regions and 48 with multiple candidate MAP+
regions (mean = 2.4, median = 2, SD = 0.6, range =
2‐4). Twelve (86%) of the 14 patients who had their
candidate MAP+ regions completely resected became
seizure‐free, 21 (66%) of the 32 patients who had their
candidate MAP+ regions partially resected became sei-
zure‐free, and 16 (44%) of the 36 patients in whom the
candidate MAP+ regions were not included in the resec-
tion became seizure‐free. Complete resection of the candi-
date MAP+ regions was not associated with better seizure
outcomes when compared to the partial resection group
(P = 0.29), but was significantly associated with better
seizure outcomes when compared to the no resection
group (P = 0.011) and the partial/no resection groups
combined (P = 0.037).
TABLE 1 Detailed demographics and clinical data of the 104 patients studied
Factor Summary Seizure‐free Not seizure‐free P
Age, y Mean = 32.3 ± 14.2 (SD),
range = 5‐65, median = 32
33.8 ± 14.6 (SD),
range = 7‐65, median = 32
30.2 ± 13.5 (SD), range = 5‐64,
median = 31.5
0.51a
Age group, n (%)
Age ≥ 18 y 84 (80.8) 52 32 0.33b
Age < 18 y 20 (19.2) 10 10
Epilepsy duration, y 14.3 ± 11.3 (SD), range = 1‐53 14.7 ± 11.3 (SD), range = 1‐51 13.8 ± 11.3 (SD), range = 1‐53 0.36c
Gender, n (%)
Female 50 (48.1) 33 17 0.20b
Male 54 (51.9) 29 25
Handedness, n (%)
Right 90 (86.5) 53 37 0.70b
Left 12 (11.5) 7 5
Ambidextrous 2 (2) 2 0
Resection type, n (%)
Temporal 62 (59.6) 41 21 0.1b
Frontal 19 (18.3) 13 6
Parietal 8 (7.7) 3 5
Occipital 1 (1.0) 1 0
Cingulate 2 (1.9) 1 1
Insular 1 (1.0) 0 1
Multilobar 11 (10.6) 3 8
Invasive evaluation type, n (%)
Subdural grid, with or
without depth
18 (24) 14 4 0.1b
Stereotactic EEG 55 (73) 29 26
Both 2 (3) 0 2
MRI, n (%)
1.5 T 25 (24) 16 9 0.61b
3 T 79 (76) 46 33
Associations between parameters and seizure outcome at 12 months were tested. Testing of handedness was performed as right versus all others. Testing of resection
type was performed as temporal resection versus all others. Testing of invasive evaluation type was performed as subdural grid versus stereotactic EEG. Two patients
had subdural grid and stereotactic EEG on two different evaluations.
EEG, electroencephalography; MRI, magnetic resonance imaging; SD, standard deviation.
at test.
bPearson chi‐square test.
cWilcoxon rank-sum test.
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3.3 | QPET
QPET analysis on 104 patients revealed 28 lobar localiza-
tions, 30 unilateral multilobar findings, four bitemporal
findings with clear asymmetry, one bitemporal finding
without clear asymmetry, 32 bilateral findings (more exten-
sive than bitemporal), and nine negative findings at the SD
threshold of −2. Lobar localization on QPET was not asso-
ciated with better seizure outcomes (P = 0.56). In the 95
patients with positive QPET findings, nine (69%) of the 13
patients who had their QPET regions completely resected
became seizure‐free (mostly comprised of lobectomies of
the hypometabolic temporal lobe); 48 (58%) of the 82
patients in whom the QPET regions were not completely
resected became seizure‐free. Complete resection of the
QPET regions was not associated with seizure‐free out-
come when compared with the partial/no resection groups
combined (P = 0.55). In the 62 patients with temporal lobe
epilepsy, nine patients had bilateral temporal hypometabo-
lism shown by QPET. Asymmetry index analysis deter-
mined the side concordant with surgery in five of these
nine patients (56%).
3.4 | QPET‐MAP
Combined QPET‐MAP analysis was performed on the 82
patients who had candidate MAP+ regions. Table 2 shows
the data of QPET‐MAP analyses at SD thresholds of −1,
−2, −3, and −4. The positive rate of QPET‐MAP was 74%
(77 of 104) with SD = −1, 55% (57 of 104) with SD =
−2, 40% (42 of 104) with SD = −3, and 22% (23 of 104)
with SD = −4. At SD = −1, −2, and −3, complete resec-
tion of the QPET‐MAP+ region was significantly associ-
ated with seizure‐free outcome when compared with the
partial resection group (P = 0.023, P < 0.001, P = 0.006,
respectively), the no resection group (P = 0.002,
P < 0.001, P = 0.001, respectively), or the partial/no
resection groups combined (P < 0.001 for all three thresh-
olds). At SD = −4, complete resection of the QPET‐MAP+
region was not significantly associated with seizure‐free
outcome when compared with the partial resection group
(P = 0.119) or the no resection group (P = 0.153), likely
due to small sample size. Significance was observed when
the partial resection group and the no resection group were
combined (P = 0.04).
Data for sensitivity and specificity analysis are detailed
in Table 3. The threshold of SD = −2 showed the best
combination of positive rate (55%), sensitivity (0.68),
specificity (0.88), positive predictive value (0.88), and neg-
ative predictive value (0.69). At this threshold, re‐review of
the original MRI scan with a dedicated neuroradiologist
confirmed the abnormalities in 88% (50 of 57). Figures 2
and 3 illustrate example patients whose QPET‐MAP+
regions were included in the resection and who became sei-
zure‐free.
3.5 | Temporal versus extratemporal
We performed subgroup analysis for the 62 patients with
temporal lobe epilepsy and the 42 patients with extratem-
poral lobe epilepsy at threshold of SD = −2. In the
extratemporal group, complete resection of QPET‐MAP+
regions was positively associated with a seizure‐free out-
come (P < 0.01) when compared with the partial resection
group and the no resection group combined. However, in
the temporal lobe epilepsy group, the data trended toward
but did not reach significance (P = 0.054). Lobar localiza-
tion by visual PET analysis was not associated with better
seizure outcomes in either the temporal or the extratempo-
ral group (P = 0.35, P = 0.53, respectively). Lobar local-
ization by QPET analysis itself (not combined with MAP)
TABLE 2 Correlation between resection of QPET‐MAP+ regions
and seizure outcomes
Groups, N = 82 Total
Seizure‐
free,
12 mo
Not
seizure‐free,
12 mo P
SD = −1
Complete resection 23 20 3 <0.001*
Partial resection 23 12 11 0.023
No resection 31 13 18 0.002
Negative 5 4 1
SD = −2
Complete resection 25 22 3 <0.001*
Partial resection 11 3 8 <0.001
No resection 21 7 14 <0.001
Negative 25 17 8
SD = −3
Complete resection 19 16 3 <0.001*
Partial resection 8 2 6 0.006
No resection 15 4 11 0.001
Negative 40 27 13
SD = −4
Complete resection 10 7 3 0.040*
Partial resection 5 1 4 0.119
No resection 8 2 6 0.153
Negative 59 39 20
P values were generated by Fisher's exact test. The complete resection sub-
group was compared with the partial resection and no resection subgroups sep-
arately, and also compared with combined subgroups to perform the statistical
tests (P values indicated by *).
MAP, morphometric analysis program; QPET, quantitative positron emission
tomography; SD, standard deviation.
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was not associated with better seizure outcomes in either
the temporal or the extratemporal group (P = 0.21,
P = 0.43, respectively).
3.6 | Three tesla versus 1.5 tesla
We further performed subgroup analysis for the 79 patients
with 3‐T MRI and the 25 patients with 1.5‐T MRI, at
threshold of SD = −2. In the 3‐T group, complete resec-
tion of QPET‐MAP+ regions was positively associated with
a seizure‐free outcome when compared with the partial
resection group (P = 0.001), the no resection group
(P = 0.003), and the partial/no resection groups combined
(P < 0.001). However, in the 1.5‐T group, complete resec-
tion of QPET‐MAP+ regions did not positively associate
with a seizure‐free outcome when compared with the par-
tial resection group (P = 0.4), the no resection group
(P = 0.07), or combined (P = 0.1). Note that there were
only 25 patients with 1.5‐T MRI, and the small sample size
could have contributed to the insignificance.
3.7 | Pathology in patients with
QPET‐MAP+ regions
A total of 36 patients had complete or partial resection of
their QPET‐MAP+ regions at threshold of SD = −2. Posi-
tive pathology was found in 32 patients (89%), including
FCD in 28, HS in one, microglial cell proliferation in one,
and remote infarct in two. In the 28 patients with FCD,
FCD IIb was seen in five patients, IIa in five patients, Ib in
12 patients, and Ic in six patients. Notably, all patients who
had FCD type IIb (five of five) and type IIa (five of five)
in their surgical specimen had the abnormalities confirmed
after re‐review by the neuroradiologist.
3.8 | Late seizure recurrence
There were 10 patients who became seizure‐free at 1‐year
follow‐up without complete resection of the QPET‐MAP+
regions at the threshold of SD = −2. Five of these 10
patients had seizure recurrence after the first year of
follow‐up (two patients in year 2, one in year 3, and two
in year 4). Pathology of the five patients with late seizure
recurrence showed two gliosis, one Ib, one Ic, and one nor-
mal.
3.9 | Multiple QPET‐MAP+ regions
Twelve patients had multiple QPET‐MAP+ regions (aver-
age = 2.08, median = 2, SD = 0.29, range = 2‐3) at the
threshold of SD = −2. Eight had the QPET‐MAP+ regions
on the ipsilateral side of the resection (three became sei-
zure‐free); in one patient, the abnormality was contralateral
to the resection (this patient became seizure‐free); in three
patients, the abnormalities were bilateral (one became sei-
zure‐free).
4 | DISCUSSION
This retrospective study of a large surgical series with post-
operative seizure outcomes reveals the usefulness of
QPET‐MAP analysis in detecting potentially epileptogenic
lesions, particularly subtle FCD, in patients considered to
have a negative MRI by visual analysis. Results from the
automated QPET‐MAP analysis were reaffirmed by a neu-
roradiologist and a nuclear medicine physician. The associ-
ation found between the resection of the QPET‐MAP+
regions and good seizure outcome is a strong argument in
favor of incorporating a multimodal noninvasive approach
into the process of epilepsy presurgical evaluation, particu-
larly in the setting of MRI with no apparent lesion or sub-
tle suspected lesion. The high percentage of patients with
FCD upon pathological examination validates the QPET‐
MAP technique in uncovering potentially epileptic sub-
strates in patients with MRI‐negative epilepsy.
4.1 | MAP and QPET used alone and in
combination
The most important finding from this study is that the com-
bined MAP and QPET approach has a better yield than
TABLE 3 Positive rate,
sensitivity, specificity, PPV, and NPV
of QPET‐MAP at four thresholds
SD = −1 SD = −2 SD = −3 SD = −4
Positive rate 74% 55% 40% 22%
Sensitivity (95% CI) 0.44 (0.30‐0.60) 0.68 (0.50‐0.84) 0.72 (0.50‐0.89) 0.70 (0.35‐0.93)
Specificity (95% CI) 0.91 (0.75‐0.98) 0.88 (0.69‐0.97) 0.85 (0.62‐0.97) 0.77 (0.46‐0.95)
PPV (95% CI) 0.87 (0.66‐0.97) 0.88 (0.69‐0.97) 0.84 (0.60‐0.97) 0.70 (0.35‐0.93)
NPV (95% CI) 0.54 (0.40‐0.67) 0.69 (0.50‐0.84) 0.74 (0.52‐0.90) 0.77 (0.46‐0.95)
CI, confidence interval; MAP, morphometric analysis program; NPV, negative predictive value; PPV, positive
predictive value; QPET, quantitative positron emission tomography; SD, standard deviation.
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either QPET or MAP used alone. When MAP is used
alone, complete resection of candidate MAP+ regions was
significantly associated with seizure‐free outcomes when
compared with the partial and no resection groups com-
bined (P = 0.037); however, most of the significance came
from the 34 patients who had a single candidate MAP+
region. When faced with multiple candidate MAP+ regions,
distinguishing the true‐positive finding from the false‐
positive findings is a paramount task. In previous studies, a
necessary final step of the MAP methodology is a focused
re‐review of the MRI by a neuroradiologist using T1, T2,
and fluid‐attenuated inversion recovery data, to assess for
the presence or absence of a subtle but visually identifiable
structural change concordant with the MAP‐detected
region.6,11,13 This final step is crucial, as suprathreshold
regions on the junction output of MAP (or any postpro-
cessing technique) can be caused by imaging artifacts, reg-
istration errors, or normal variants, and can resemble a
FIGURE 2 Examples of five patients who had a single quantitative positron emission tomography (QPET)‐morphometric analysis program
(MAP)+ region that was completely included in the surgical resection. In Figures 2 and 3, an SD of −2 was used as the QPET threshold, and the
QPET‐MAP+ abnormalities were all confirmed by the neuroradiologist re‐review. The crosshairs indicate the location of the MAP+ candidate.
First column: T1‐weighted magnetization prepared rapid acquisition with gradient echo images used during presurgical evaluation. Second
column: gray‐white matter junction z score file, as the output of MAP processing of the T1‐weighted image shown in the first column. Third
column: T2‐weighted fluid‐attenuated inversion recovery or T2‐weighted turbo spin echo images, chosen to best depict the MAP+ candidate.
Arrows indicate that there were accompanying T2‐weighted changes in the MAP+ candidate, and the absence of an arrow indicates that there
were no corresponding T2 changes. Fourth column: QPET images as the output of statistic quantitative analysis of the original
fluorodeoxyglucose (FDG)‐PET image shown in the fifth column. The blue region indicates the hypometabolism, which is consistent with the
MAP+ candidate in a lobar range. Fifth column: the original attenuation‐corrected FDG‐PET images used during presurgical evaluation. Sixth
column: postsurgical magnetic resonance imaging indicating site and extent of resection. A, B, QPET‐MAP+ region in the frontal lobe; C,
QPET‐MAP+ region in the temporal lobe; D, E, QPET‐MAP+ region in the frontal operculum. All five cases demonstrate complete resection of
the QPET‐MAP+ region, and all patients remained seizure‐free at 12 months. Pathology: A, focal cortical dysplasia (FCD) type IIa; B, C, FCD
type Ic; D, E, FCD type IIb. In C, the image in the third column is the best available due to suboptimal slice selection
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true‐positive finding. Differentiation of these “artifacts”
from true‐positive abnormalities inevitably depends on the
skills and experience of those reviewing the data. Errors in
visual analysis may occur, and true‐positive findings may
be rejected, such as subtle lesions with only T1 signal
changes, which would appear normal on T2‐weighted
sequences.13
When PET is used alone, lobar localization yielded by
visual PET analysis or QPET was not associated with sei-
zure‐free outcome. This finding is not surprising, as PET
often shows areas of hypometabolism extending beyond
the epileptogenic region and hence is best suited for lateral-
ization and lobar localization of the potentially epilepto-
genic region rather than as a precise determination of
surgical margins.19 There is, however, a small subset of
patients whose PET studies showed focal abnormalities,
particularly the type II group, as exemplified in Figure 1A
and 1E.
When used together, the resection of QPET‐MAP+
abnormalities was significantly associated with seizure‐free
outcomes (P < 0.001). This is likely due to two factors.
First, in the face of multiple candidate MAP+ regions, the
epileptogenic subtle abnormalities were kept because of
their lobar concordance with QPET, thus excluding those
candidate MAP+ regions that were likely caused by imag-
ing artifacts, registration errors, or nonepileptic variants.
Second, the broader localization of QPET is complemented
by the more precise localization of potential structural
abnormalities identified by MAP. Yield of the combined
approach is even higher than the one described in our pre-
vious reports using MAP guided by expert neuroradiologist
review (56%),13 suggesting that a combined QPET‐MAP
approach may be a more sensitive method for the identifi-
cation of subtle epileptogenic lesions.
4.2 | QPET‐MAP findings and surgery
The successful strategy of combining data from multiple
noninvasive modalities (structural, electrophysiological, and
functional) has been previously reported. In a recent study
by Mendes Coelho et al,26 39 patients with pharmacoresis-
tant epilepsy and likely FCD were included; a similar
approach of examining concordance between QPET and
MRI was adopted, and the authors showed that QPET had
critical value for patients in the extratemporal group and
especially those with subtle MRI findings. Combination of
FIGURE 3 Examples of two patients who had multiple candidate morphometric analysis program (MAP)+ regions and quantitative positron
emission tomography (QPET) helped distinguish the regions that were relevant to the epilepsy. A, Two candidate MAP+ regions; the one in the right
parietal region was QPET‐MAP+ and resected (A1), and the other one in the left temporal region was discordant with QPET (therefore QPET‐
MAP−) and unresected (A2). B, Two candidate MAP+ regions; the one in the right frontal region was QPET‐MAP+ and resected (B1), and the other
one in the left frontal region was discordant with QPET and unresected (B2). Both cases demonstrate complete resection of the QPET‐MAP+ region,
and both patients remained seizure‐free at 12 months. Pathology: A‐1, focal cortical dysplasia (FCD) type IIb; B1, FCD type Ib
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MRI and PET postprocessing was adopted in a surface‐
based framework assisted by machine learning in a very
recent study that included 28 patients with histopathologi-
cally proven FCD.32 The authors showed that the classifier
using combined features from MRI and PET outperformed
both quantitative MRI by itself and multimodal visual anal-
ysis. In a previous study from our group, we showed that
MAP+ regions with concordant MEG findings were more
likely to be epileptogenic in a cohort of 25 MRI‐negative
patients.12 Widjaja et al33 examined PET and MEG in 26
patients with nonlesional MRI and showed that the combi-
nation of PET and MEG increased specificity and positive
predictive value. Perissinotti et al34 studied 54 children (26
MRI‐negative) and reported that combination of PET and
single photon emission CT had localizing results in as high
as 76% of the cases. Despite different patient populations
and study approaches, these published studies along with
our current results suggest that correlating findings from
multiple functional and neurophysiological methods
improves the identification of epileptogenic pathologies.
4.3 | Temporal lobe versus extratemporal
lobe epilepsies
Consistent with the previous literature,26 our data suggest
that QPET‐MAP performs better in the extratemporal group
than the temporal group. This is probably due to the high
proportion of QPET‐MAP–negative cases in the temporal
group (55%) as compared to the extratemporal group
(31%). Note that because of the small number of cases with
HS (2%) in surgical pathology, our findings are likely to
be more pertinent in those patients with nonlesional neo-
cortical temporal lobe epilepsies,35,36 rather than patients
with classical mesial temporal lobe epilepsies, who are
more likely to be MRI‐positive. Interestingly, lobar local-
ization of PET hypometabolism by visual analysis or QPET
analysis itself (not combined with MAP) did not carry any
significant association with seizure‐free outcome, further
demonstrating challenges presented in this MRI‐negative
cohort.
4.4 | Asymmetry index analysis in temporal
cases
Bilateral temporal hypometabolism can exist in about 10%
of patients with medically intractable temporal lobe epi-
lepsy.37,38 Although these findings may suggest bitemporal
independent epileptogenicity, the presence of unilateral
mesial temporal epileptic focus with bilateral HS cannot be
excluded.20,39 The asymmetry index analysis used in this
study helped lateralize the epilepsy side correctly in 56%
(five of nine) of the patients with bilateral temporal hypo-
metabolism. This is consistent with other studies showing
additional lateralization help from asymmetry index analy-
sis,29 or combination of asymmetry index and extent analy-
sis.24
4.5 | Clinical relevance
It is beneficial to ponder the clinical relevance of our
findings in the context of preoperative localization and
outcome prediction. MAP is considered one of the most
well‐studied and successful voxel‐based techniques for
FCD detection40 and has already been set up in more than
30 centers around the world. QPET can be included as
part of the work flow on any Siemens PET/CT scanner. It
is foreseeable that combined MAP and QPET analysis
results can be provided for consideration (as another non-
invasive tool) at multimodal patient management discus-
sions. This process will be especially relevant to those
patients with initially negative MRI by visual analysis. If
the detected QPET‐MAP+ abnormality is consistent with
other electroclinical data, is reaffirmed by the neuroradiol-
ogist, and is in a location that is completely resectable,
seizure outcome is likely favorable. However, if the reaf-
firmed finding is in a location that overlaps with eloquent
areas and will likely not be completely resected (unless a
deficit is acceptable), seizure outcome is likely unfavor-
able. This information can be useful for discussion with
the patient and family. QPET‐MAP should be used as a
localization test rather than a screening test, because the
absence of QPET‐MAP+ abnormality does not preclude
the chance of patients becoming seizure‐free, as evidenced
by our data.
4.6 | Limitations
Patients included in our study were assessed over a 6‐year
period. Over time, the presurgical evaluation process was
not necessarily the same at the beginning and end of this
6‐year epoch. For example, 1.5‐T MRI was used for earlier
patients and 3‐T MRI was used for more recent patients.
This may have contributed to heterogeneity in the surgical
cohort.
Twenty‐one of the 104 patients were younger than 19
years of age and therefore outside of the age range (19‐
44 years) of the PET normal control database; all of them
had positive QPET findings. This age mismatch may con-
tribute to more false‐positive findings, as reported previ-
ously.41
5 | CONCLUSIONS
We present a practical and effective approach that combi-
nes quantitative analyses of functional (QPET) and
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structural (MAP) imaging data to facilitate automated and
objective identification of subtle epileptogenic abnormali-
ties. The efficacy of this approach is demonstrated in a
large cohort of MRI‐negative surgical patients with known
pathology and postresective seizure outcomes. This study
demonstrates the benefit of combining quantitative analyses
of functional and structural imaging modalities in identify-
ing epileptogenic lesions, as has been demonstrated for the
integration of other modalities, including MRI, electroen-
cephalography, and MEG. Our findings suggest that this
approach may be useful in the evaluation of many and per-
haps most patients who have no apparent lesions on struc-
tural MRI.
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